Iridex (IRIX) Current Deferred Revenue (2016 - 2025)
Historic Current Deferred Revenue for Iridex (IRIX) over the last 15 years, with Q3 2025 value amounting to $2.2 million.
- Iridex's Current Deferred Revenue fell 543.9% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 543.9%. This contributed to the annual value of $2.2 million for FY2024, which is 8249.26% down from last year.
- Iridex's Current Deferred Revenue amounted to $2.2 million in Q3 2025, which was down 543.9% from $2.3 million recorded in Q2 2025.
- In the past 5 years, Iridex's Current Deferred Revenue registered a high of $14.9 million during Q3 2022, and its lowest value of $1.2 million during Q1 2021.
- In the last 5 years, Iridex's Current Deferred Revenue had a median value of $12.5 million in 2021 and averaged $8.9 million.
- In the last 5 years, Iridex's Current Deferred Revenue skyrocketed by 98272.21% in 2022 and then plummeted by 8263.97% in 2024.
- Over the past 5 years, Iridex's Current Deferred Revenue (Quarter) stood at $12.4 million in 2021, then increased by 13.69% to $14.2 million in 2022, then dropped by 12.18% to $12.4 million in 2023, then crashed by 82.49% to $2.2 million in 2024, then rose by 1.47% to $2.2 million in 2025.
- Its Current Deferred Revenue was $2.2 million in Q3 2025, compared to $2.3 million in Q2 2025 and $2.1 million in Q1 2025.